Healthlead PCLBKK:HL +0.90%72 Market Cap is ฿1,423 Mil as of Jul. 05, 2026. GuruFocus rates BKK:HL with a GF Score™ of 72/100 and a GF Value™ of ฿10.84 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 692 Healthcare Providers & Services companies, Healthlead PCL ranks worse than 64.16% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Healthlead PCL's share price for the quarter that ended in Mar. 2026 was ฿6.15. Healthlead PCL's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 256 Mil. Therefore, Healthlead PCL's market cap for the quarter that ended in Mar. 2026 was ฿1,577 Mil.
Healthlead PCL's quarterly market cap
declined
from Sep. 2025 (฿2,025 Mil) to Dec. 2025 (฿1,946 Mil) and
declined
from Dec. 2025 (฿1,946 Mil) to Mar. 2026 (฿1,577 Mil).
Healthlead PCL's annual market cap
declined
from Dec. 2023 (฿2,829 Mil) to Dec. 2024 (฿2,774 Mil) and
declined
from Dec. 2024 (฿2,774 Mil) to Dec. 2025 (฿1,946 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Healthlead PCL's Enterprise Value for Today is ฿1,213 Mil.
Healthlead PCL (BKK:HL) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Healthlead PCL Market Cap Related Terms
Healthlead PCL Market Cap Historical Data
* Premium members only.
The historical data trend for Healthlead PCL's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Healthlead PCL's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Healthlead PCL Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Healthlead PCL's Market Cap distribution charts can be found below:
* The bar in red indicates where Healthlead PCL's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Healthlead PCL's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Healthlead PCL (BKK:HL) has a Market Cap of ฿1,423 Mil as of Jul. 05, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Healthlead PCL and its competitors. According to the industry distribution chart, Healthlead PCL ranks #444 out of 692 companies in the Healthcare Providers & Services industry, placing it in the top 64.2%.
Is Healthlead PCL's Market Cap too high?
Healthlead PCL's current Market Cap is ฿1,423 Mil. Based on the distribution chart, Healthlead PCL ranks #444 out of 692 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Healthlead PCL has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Healthlead PCL's Market Cap compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Healthlead PCL ranks #444 out of 692 companies for Market Cap. This places Healthlead PCL in the lower half of its industry. The industry median Market Cap is 98.30. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 98.30, based on 692 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Healthlead PCL and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 98.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Healthlead PCL's current Market Cap is ฿1,423 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healthlead PCL stock overvalued right now?
Based on GuruFocus' analysis, Healthlead PCL (BKK:HL) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿10.84, compared to a current price of ฿5.60 — trading 48.3% below its estimated fair value. The current Market Cap is ฿1,423 Mil. Healthlead PCL's overall GF Score™ is 72/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Healthlead PCL (BKK:HL), the current Market Cap is ฿1,423 Mil as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Healthlead PCL (BKK:HL) Overvalued in 2026?
Based on GuruFocus' analysis, Healthlead PCL stock appears to be undervalued.
The current stock price of ฿5.60 is trading 48.3% below its estimated GF Value™ of ฿10.84.
GuruFocus considers Healthlead PCL to be Significantly Undervalued.
Key valuation signals for BKK:HL:
Market Cap: ฿1,423 Mil
GF Value™: ฿10.84 vs. price of ฿5.60 (48.3% below fair value)
No single metric tells the full story. See the BKK:HL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Healthlead PCL is a holding company. Along with its subsidiaries, it operates a pharmacy business under iCare, Pharmax, vitaminclub, and Super Drug brands, distributing medicines, medical supplies, cosmeceuticals, dietary supplements, medical devices, and other healthcare products. Additionally, it is involved in co-inventing and co-developing healthcare products in collaboration with external research teams and contract manufacturers, producing and distributing its own branded products. Geographically, the group operates only in Thailand.
72GF Score
Get the complete analysis for BKK:HL
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:HL has been successfully added to your 
